Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Early Hum Dev ; 114: 11-15, 2017 11.
Article in English | MEDLINE | ID: mdl-28919246

ABSTRACT

Challenges in treating severe neonatal jaundice in low and middle-income country settings still exist at many levels. These include: a lack of awareness of causes and prevention by families, communities and even sometimes health care professionals; insufficient, ineffective, high quality affordable diagnostic and therapeutic options; limited availability of rehabilitation provision for kernicterus. Collectively these challenges lead to an unacceptably high global morbidity and mortality from severe neonatal jaundice. In the past decade, there has been an explosion of innovations addressing some of these issues and these are increasingly available for scale up. Scientists, healthcare providers, and communities are joining hands to explore educational tools, low cost screening and diagnostic options including at point-of-care and treatment modalities including filtered sunlight and solar powered phototherapy. For the first time, the possibility of eliminating the tragedy of preventable morbidity and mortality from severe NNJ is on the horizon, for all.


Subject(s)
Heliotherapy/methods , Jaundice, Neonatal/prevention & control , Phototherapy/methods , Developing Countries , Female , Heliotherapy/economics , Humans , Infant, Newborn , Jaundice, Neonatal/diagnosis , Jaundice, Neonatal/epidemiology , Jaundice, Neonatal/therapy , Phototherapy/economics
2.
Acta Derm Venereol ; 96(2): 241-4, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26258496

ABSTRACT

Daylight-mediated photodynamic therapy (DL-PDT) is considered as effective as conventional PDT using artificial light (light-emitting diode (LED)-PDT) for treatment of actinic keratoses (AK). This randomized prospective non-sponsored study assessed the cost-effectiveness of DL-PDT compared with LED-PDT. Seventy patients with 210 AKs were randomized to DL-PDT or LED-PDT groups. Effectiveness was assessed at 6 months. The costs included societal costs and private costs, including the time patients spent in treatment. Results are presented as incremental cost-effectiveness ratio (ICER). The total costs per patient were significantly lower for DL-PDT (€132) compared with LED-PDT (€170), giving a cost saving of €38 (p = 0.022). The estimated probabilities for patients' complete response were 0.429 for DL-PDT and 0.686 for LED-PDT; a difference in probability of being healed of 0.257. ICER showed a monetary gain of €147 per unit of effectiveness lost. DL-PDT is less costly and less effective than LED-PDT. In terms of cost-effectiveness analysis, DL-PDT provides lower value for money compared with LED-PDT.


Subject(s)
Health Care Costs , Heliotherapy/economics , Keratosis, Actinic/economics , Keratosis, Actinic/therapy , Photochemotherapy/economics , Photochemotherapy/instrumentation , Aged , Aged, 80 and over , Cost Savings , Cost-Benefit Analysis , Female , Heliotherapy/adverse effects , Humans , Keratosis, Actinic/diagnosis , Male , Middle Aged , Photochemotherapy/adverse effects , Prospective Studies , Time Factors , Treatment Outcome
3.
Acta Derm Venereol ; 96(5): 664-8, 2016 Jun 15.
Article in English | MEDLINE | ID: mdl-26714522

ABSTRACT

There are few studies evaluating the cost-effectiveness of self-management interventions for patients with psoriasis. Motivational interviewing (MI) as a telephone follow-up after climate-heliotherapy was effective on several clinical parameters, but its cost-effectiveness is unknown. A cost-utility analysis was conducted alongside a randomized controlled trial (RCT) comparing MI with usual care. A total of 169 Norwegian patients were included. A within-trial analysis compared the costs and quality-adjusted life years (QALYs). Utilities were measured with the 15D instrument, supplemented with Dermatological Life Quality Index (DLQI). A time-integrated summary score defined the clinical effects. QALYs were adjusted for baseline differences. MI provided equivalent quality of life and utility (15D: -0.0022 QALYs (95% Cl -0.02, 0.01), p = 0.77, and DLQI: -0.62 QALYs (95%CI -0.65, 0.41), p = 0.24, at lower costs €-1103 (-2293, 87), p = 0.058, compared with treatment-as-usual. The MI intervention was thus cost-effective. This result was more evident when using the DLQI as outcome measure compared with 15D.


Subject(s)
Cost-Benefit Analysis , Heliotherapy/economics , Motivational Interviewing/economics , Psoriasis/therapy , Self Care/economics , Female , Humans , Male , Middle Aged , Norway , Quality of Life , Quality-Adjusted Life Years , Treatment Outcome
4.
J Hist Sociol ; 25(1): 83-105, 2012.
Article in English | MEDLINE | ID: mdl-22611579

ABSTRACT

This paper traces the emergence of the therapeutic use of sunlight in medicine during the first half of the twentieth century. This was a period of considerable flux in medicine with various strands of practice and theory competing. Drawing on two case studies of sunlight therapy, both artificial (actinotherapy) and natural (heliotherapy), in the treatment of rickets and tuberculosis this paper will explore how medicine was constituted within these regimes. The paper will argue that therapeutic and clinical applications of sunlight helped establish an association between sunlight and health but also defined a particular and specific performance of medicine.


Subject(s)
Heliotherapy , Hygiene , Sunlight , Therapeutics , Ultraviolet Therapy , Heliotherapy/economics , Heliotherapy/history , Heliotherapy/psychology , History of Medicine , History, 20th Century , Hygiene/education , Hygiene/history , Rickets/economics , Rickets/ethnology , Rickets/history , Rickets/psychology , Therapeutics/history , Tuberculosis/economics , Tuberculosis/ethnology , Tuberculosis/history , Tuberculosis/psychology , Ultraviolet Therapy/economics , Ultraviolet Therapy/history , Ultraviolet Therapy/psychology
5.
Int J Dermatol ; 39(1): 59-69, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10651969

ABSTRACT

BACKGROUND: About 21% of the patients coming yearly to the DMZ Clinic at the Dead Sea for climatotherapy suffer from atopic dermatitis. This is a common, chronic, and relapsing disease which necessitates drug treatment (topical corticosteroids, antimicrobials, antihistamines, or immunomodulators), phototherapy, or climatotherapy. Objective and methods As the improvement in the condition of patients after 4 weeks of climatotherapy at the Dead Sea is remarkable, we undertook to evaluate the demographic factors that have the strongest impact on this beneficial effect, in adults and children. The major factors studied were: gender, previous medical history, previous stays at the Dead Sea, skin type, skin involvement, age, and duration of treatment. Results A retrospective study of 1718 patients revealed that previous treatments at the Dead Sea and stays longer than 4 weeks caused a clearance greater than 95%, the length of sun exposure was no longer than 5 h daily, and there was no impact of the percentage of skin involvement on the clearance of patients staying more than 4 weeks. CONCLUSION: s Climatotherapy of atopic dermatitis at the Dead Sea is a highly effective modality for treating this disease. It is also a highly cost-effective method, as the patients take no medications and experience no side-effects. Successful climatotherapy of atopic dermatitis requires strict medical supervision throughout the whole length of the patient's stay on shore.


Subject(s)
Climatotherapy , Dermatitis, Atopic/therapy , Heliotherapy , Adolescent , Adult , Age Factors , Child , Child, Preschool , Climatotherapy/economics , Cost-Benefit Analysis , Female , Heliotherapy/economics , Humans , Israel , Male , Relaxation Therapy/economics , Retrospective Studies , Seawater , Sex Factors , Sunlight , Treatment Outcome
6.
Kinesiologia ; (51): 17-9, jun. 1998.
Article in Spanish | LILACS | ID: lil-228902

ABSTRACT

La helio-oxígeno terapia es un método terapéutico relativamente nuevo en Chile, sin embargo, su utilización se conoce ya desde 1934 por los estudios de Barach et.al. El helio (He) es un gas inerte que, por sus características de muy baja densidad (1/8 de la densidad del nitrógeno), al mezclarlo con oxígeno dísminuye la densidad de éste. La utilidad de la mezcla helio-oxígeno o Heliox radica en su capacidad de disminuir la resistencia al paso del flujo gaseoso permitiendo su difusión a través de espacios aéreos estrechos; es por ello que en enfermedades como obstrucción de la vía aérea alta, asma y enfermedades pulmonares obstructivas crónicas, su administración ha resultado en mejorías de la relación VIQ, disminución de P a CO, y menor trabajo respiratorio, proyectándose como herramienta segura y sin efectos deletéreos para los pacientes


Subject(s)
Humans , Heliotherapy , Lung Diseases, Obstructive/therapy , Oxygen Inhalation Therapy/methods , Health Care Costs , Heliotherapy/economics , Helium/administration & dosage , Helium/pharmacology , Respiration, Artificial/methods
7.
Br J Dermatol ; 138(2): 288-92, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9602876

ABSTRACT

A 2-year trial was conducted to evaluate the cost-effectiveness of heliotherapy for psoriasis. The course and cost of psoriasis of 46 Finnish patients were first closely monitored for 1 year, then the patients received a 4-week supervised heliotherapy treatment in the Canary Islands, Spain, after which they continued to be followed for another year. Heliotherapy dramatically reduced the severity of psoriasis and also seemed to have favourable long-term effects on psoriasis. The mean direct cost of the 4-week heliotherapy for one patient was FIM12,289 (1 Pound = FIM7.0 in 1989). The cost of flights and half-board in Spain formed nearly 60% (FIM7033) of the total cost. In the year preceding heliotherapy, the mean direct annual cost of antipsoriasis therapy was FIM7335 and in the year after FIM5700, a reduction of 22% in annual costs; this change was not statistically significant because there were large variations in costs among patients. The costs of heliotherapy exceeded manyfold the mean monthly cost of conventional psoriasis therapy. There were no overall savings using heliotherapy in those patients suffering mainly from moderately severe psoriasis. Heliotherapy saved costs only in those patients with severe psoriasis that required expensive medication or ward treatment. Although heliotherapy cannot be regarded as an economical treatment for the average patients with psoriasis, it clears psoriasis effectively and is preferred by patients. Thus, heliotherapy constitutes an alternative for patients suffering severe psoriasis.


Subject(s)
Heliotherapy/economics , Psoriasis/economics , Adult , Cost-Benefit Analysis , Costs and Cost Analysis , Evaluation Studies as Topic , Female , Finland , Follow-Up Studies , Humans , Male , Middle Aged , Psoriasis/therapy , Regression Analysis , Severity of Illness Index , Spain , Travel/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...